Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms
Funding led by Guozhong Capital will accelerate Phase 2 development for saRNA candidate RAG-01 and CNS asset RAG-17, advance systemic saRNA program RAG-18 toward IND, and expand extrahepatic RNA delivery technologies. NANTONG, China, July 29, 2026...
ROBOTERA Raises Over USD 200 Million in New Round Led by SF Group, HSG and IDG Capital
BEIJING, May 8, 2026 /PRNewswire/ -- Following its RMB 1 billion strategic round in March, robotics company ROBOTERA has raised over USD 200 million in a new financing round led by SF Group. The round also saw participation from leading financial...
D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs
SHANGHAI, Dec. 10, 2025 /PRNewswire/ -- D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round. The...
FUTURE FUND OMAN LAUNCHES FIRST WAVE OF INVESTMENT PROJECTS WORTH OVER US$ 2 BILLION
MUSCAT, Oman, Nov. 20, 2024 /PRNewswire/ -- Future Fund Oman (FFO), the latest investment initiative under Oman Investment Authority (OIA), has announced its first batch of approved investment projects. With a combined value exceeding US$ 2 billion,...